121 related articles for article (PubMed ID: 35645211)
41. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
42. Red blood cell exchange in an emergency in sickle cell disease.
Hequet O; Fort R; Driss F
Transfus Apher Sci; 2020 Dec; 59(6):102996. PubMed ID: 33189570
[TBL] [Abstract][Full Text] [Related]
43. Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease.
Lopez Domowicz DA; Welsby I; Esther CR; Zhu H; Marek RD; Lee G; Shah N; Poisson JL; McMahon TJ
Blood Transfus; 2020 May; 18(3):200-207. PubMed ID: 32203007
[TBL] [Abstract][Full Text] [Related]
44. [Management of high risk pregnancy in sickle cell disease by a strategy of prophylactic red cell transfusion or automated red cell exchange].
Driss F; Tertian G; Becquemont L; Haddad B; Cynober T; Raphael M; Tchernia G
Transfus Clin Biol; 2007 Oct; 14(4):386-92. PubMed ID: 18035571
[TBL] [Abstract][Full Text] [Related]
45. Effect of canakinumab on clinical and biochemical parameters in acute gouty arthritis: a meta-analysis.
Jena M; Tripathy A; Mishra A; Maiti R
Inflammopharmacology; 2021 Feb; 29(1):35-47. PubMed ID: 32918702
[TBL] [Abstract][Full Text] [Related]
46. Perioperative transfusion management in patients with sickle cell anaemia undergoing a total hip arthroplasty. Is there a role of red-cell exchange transfusion? A retrospective study in the CHU of Fort-de-France Martinique.
Ould Amar K; Rouvillain JL; Loko G
Transfus Clin Biol; 2013 Mar; 20(1):30-4. PubMed ID: 23522689
[TBL] [Abstract][Full Text] [Related]
47. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
Jariwala K; Mishra K; Ghosh K
Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
[TBL] [Abstract][Full Text] [Related]
48. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
49. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
[TBL] [Abstract][Full Text] [Related]
50. Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report.
Win N; Lee E; Needs M; Chia LW; Stasi R
Transfus Med; 2012 Apr; 22(2):137-41. PubMed ID: 22233101
[TBL] [Abstract][Full Text] [Related]
51. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP).
Files B; Brambilla D; Kutlar A; Miller S; Vichinsky E; Wang W; Granger S; Adams RJ
J Pediatr Hematol Oncol; 2002 May; 24(4):284-90. PubMed ID: 11972097
[TBL] [Abstract][Full Text] [Related]
52. Hemoglobin S target of <50% as compared to 30% in chronic red cell exchange for secondary stroke prevention in sickle cell disease.
Choi J; Markantonis JE; De Simone N; Nero A; Kim J; Sarode R
J Clin Apher; 2023 Dec; 38(6):677-684. PubMed ID: 37525930
[TBL] [Abstract][Full Text] [Related]
53. A modified transfusion program for prevention of stroke in sickle cell disease.
Cohen AR; Martin MB; Silber JH; Kim HC; Ohene-Frempong K; Schwartz E
Blood; 1992 Apr; 79(7):1657-61. PubMed ID: 1558963
[TBL] [Abstract][Full Text] [Related]
54. Impact of universal irradiation on chronic transfusion for sickle cell disease.
Salinas Cisneros G; Webb J; Luban NLC; Nickel RS
Transfusion; 2021 Aug; 61(8):2290-2294. PubMed ID: 34252204
[TBL] [Abstract][Full Text] [Related]
55. Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy.
Detterich J; Alexy T; Rabai M; Wenby R; Dongelyan A; Coates T; Wood J; Meiselman H
Transfusion; 2013 Feb; 53(2):297-305. PubMed ID: 22882132
[TBL] [Abstract][Full Text] [Related]
56. Red cell exchange in sickle cell disease.
Lawson SE; Oakley S; Smith NA; Bareford D
Clin Lab Haematol; 1999 Apr; 21(2):99-102. PubMed ID: 10342068
[TBL] [Abstract][Full Text] [Related]
57. Hemoglobin Variants Acquired Post-Exchange Transfusion in Pediatric Sickle Cell Disease (SCD) Patients.
Pandey S; Cottler-Fox M; Drobena G
Ann Clin Lab Sci; 2015; 45(6):627-30. PubMed ID: 26663791
[TBL] [Abstract][Full Text] [Related]
58. [Blood transfusion assessment to 112 homozygous sickle-cell disease patients in university hospital of Brazzaville].
Dokekias AE; Ossini LN; Tsiba FO; Malanda F; Koko I; De Montalembert M
Transfus Clin Biol; 2009; 16(5-6):464-70. PubMed ID: 19369104
[TBL] [Abstract][Full Text] [Related]
59. The implementation of automated red blood cell exchange (erythrocytapheresis) as a treatment modality in sickle cell disease patients: Single center experience.
Ebeid FSE
Transfus Apher Sci; 2023 Aug; 62(4):103719. PubMed ID: 37147250
[TBL] [Abstract][Full Text] [Related]
60. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
